Japanese Pharma Firm to Pay $4B for Single Drug
Business
Japanese Pharma Firm to Pay $4B for Single Drug
2022-12-14 20:48:42
by Dan McCue

TOKYO — Japanese Pharma firm Takeda has agreed to pay $4 billion in cash for a single drug invented by Nimbus Therapeutics, a Boston, Massachusetts-based biotechnology company. The drug Takeda is buying (NDI-034858) blocks selective allosteric tyrosine kinase 2 (also... Read More

Straight From The Well
scroll top